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1130b-Catenin Stabilization in Skin Fibroblasts
Causes Fibrotic Lesions by Preventing
Adipocyte Differentiation of the
Reticular Dermis
Maria Mastrogiannaki1,2,3, Beate M. Lichtenberger1,2,3, Andreas Reimer1, Charlotte A. Collins2,
Ryan R. Driskell1 and Fiona M. Watt1The Wnt/b-catenin pathway plays a central role in epidermal homeostasis and regeneration, but how it affects
fibroblast fate decisions is unknown. We investigated the effect of targeted b-catenin stabilization in dermal
fibroblasts. Comparative gene expression profiling of stem cell antigen 1- (Sca1-) and Sca1þ neonatal fibroblasts
from upper and lower dermis, respectively, confirmed that Sca1þ cells had a preadipocyte signature and
showed differential expression of Wnt/b-catenineassociated genes. By targeting all fibroblasts or selectively
targeting Dlk1þ lower dermal fibroblasts, we found that b-catenin stabilization between developmental stages
E16.5 and P2 resulted in a reduction in the dermal adipocyte layer with a corresponding increase in dermal
fibrosis and an altered hair cycle. The fibrotic phenotype correlated with a reduction in the potential of Sca1þ
fibroblasts to undergo adipogenic differentiation ex vivo. Our findings indicate that Wnt/b-catenin signaling
controls adipogenic cell fate within the lower dermis, which potentially contributes to the pathogenesis of
fibrotic skin diseases.
Journal of Investigative Dermatology (2016) 136, 1130e1142; doi:10.1016/j.jid.2016.01.036INTRODUCTION
The epidermis is maintained by distinct subpopulations of
stem cells whose fate is regulated by intrinsic mechanisms
and external signals from the niche (Kretzschmar and Watt,
2014; Lim and Nusse, 2013). Signaling between epidermal
stem cells and cells in the underlying dermis is reciprocal
(Millar, 2002; Sennett and Rendl, 2012). Such interactions can
occur at close range—for example, via extracellular matrix
(ECM) deposition (Fujiwara et al., 2011)—and by long-range
signaling mediated by epidermal secreted factors (Collins
et al., 2011; Donati et al., 2014). Furthermore, factors
secreted by proliferating adipocyte progenitors (Festa et al.,
2011) and differentiated adipocytes (Plikus and Chuong,
2014; Plikus et al., 2008) regulate the hair growth cycle.
The dermis contains a variety of subpopulations of
mesenchymal cells with different locations and functions
(Driskell and Watt, 2015). At the E12.5 stage of embryonic1Centre for Stem Cells and Regenerative Medicine, King’s College London,
Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK; and 2Wellcome
Trust Centre for Stem Cell Research, University of Cambridge, Tennis Court
Road, Cambridge CB2 1QR, UK
3These authors contributed equally to this work.
Correspondence: Fiona M. Watt, Centre for Stem Cells and Regenerative
Medicine, King’s College London, Floor 28, Tower Wing, Guy’s Hospital,
Great Maze Pond, London SE1 9RT, UK. E-mail: fiona.watt@kcl.ac.uk
Abbreviations: DAPI, 40, 6-diamidino-2-phenylindole; DP, dermal papilla;
ECM, extracellular matrix; EGFP, enhanced green fluorescent protein; HF,
hair follicle; PDGFRa, platelet-derived growth factor receptor a; Sca1, stem
cell antigen 1
Received 23 September 2015; revised 13 January 2016; accepted 28 January
2016; accepted manuscript published online 20 February 2016; corrected
proof published online 7 April 2016
Journal of Investigative Dermatology (2016), Volume 136
ª 2016 The Author
an odevelopment, mouse dermal cells are capable of differenti-
ating into all the different fibroblast types present in postnatal
skin. However, at about E16.5, the dermal mesenchyme un-
dergoes commitment to two different lineages. In late em-
bryonic and neonatal skin, the upper dermal lineage gives
rise to papillary fibroblasts, the cells of the arrector pili
muscle (responsible for piloerection), the dermal sheath, and
the dermal papilla (DP). The lower dermal lineage gives rise
to the reticular fibroblasts, which deposit most of the skin
fibrillar collagen, preadipocytes and mature adipocytes
(Driskell et al., 2013). The different fibroblast lineages are
functionally significant, because the upper papillary lineage
is required for new hair follicle (HF) formation, and the lower
(or reticular) lineage is responsible for the first wave of dermal
repair after wounding (Driskell et al., 2013). However,
the molecular mechanisms that determine fibroblast fate
decisions are largely uncharacterized (Driskell et al., 2009).
Epidermal Wnt/b-catenin signaling causes profound
changes in the underlying dermis, leading to expansion of both
the upper and lower dermal lineages, de novo formation of
DPs, and an increase in adipocyte differentiation (Collins et al.,
2011; Donati et al., 2014; Lichtenberger et al., 2016). In
addition, there is compelling evidence that Wnt/b-catenin
signaling in fibroblasts regulates the compositionof the dermis.
b-Catenin is necessary and sufficient to specify dermal fate in
different body regions during mouse embryonic development
(Atit et al., 2006; Ohtola et al., 2008).Wnt/b-catenin signaling
has a well-characterized inhibitory effect on adipogenic dif-
ferentiation (Gesta et al., 2007; Kennell and MacDougald,
2005; Longo et al., 2004) and is required in the DP to pro-
mote HF formation and control DP activity and size (Enshell-
Seijffers et al., 2010; Kaushal et al., 2015; Tsai et al., 2014).s. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. This is
pen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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b-Catenin Regulates Fibroblast LineagesFurthermore, it was shown recently that expression of stabi-
lized b-catenin in the fibroblasts of mouse ventral dermis at
E16.5 results in progressive skin fibrosis, with thickened
collagen fibers and altered collagen fibril morphology
(Hamburg-Shields et al., 2015).
In this study, we performed comparative gene expression
profiling of distinct populations of neonatal fibroblasts, which
showed differential expression of Wnt pathway genes. Using
a conditional targeting approach, we examined the effects of
b-catenin stabilization in all fibroblasts or selectively in
reticular fibroblasts. Our findings indicate a key role of
Wnt/b-catenin signaling in regulating the differentiation of
reticular fibroblasts into adipocytes.
RESULTS
Differential expression of adipocyte genes in upper and
lower dermal fibroblasts
As previously reported (Collins et al., 2011), in PdgfraEGFP
mice (Hamilton et al., 2003) enhanced green fluorescentFigure 1. Localization and isolation of Sca1D and Sca1- dermal fibroblasts. (aed
nuclear EGFP and immunostaining for (a, b) K14 and PDGFRa, (c, d) Sca1, (n, o)
(a, c, n, p), respectively. Scale bars ¼ 150 mm. (e) Flow cytometry plot showing g
expression. (fem) Quantitative real-time PCR analysis of mRNA levels in sorted
Sca1þ. Genes were normalized to the Gapdh gene. Error bars represent standar
***P  0.0005 compared with GFP- cells; #p  0.05 compared with EGFPþ/Sca
fluorescent protein; GFP, green fluorescent protein; HF, hair follicle; pap, papillaprotein (EGFP) expressed under the control of the platelet-
derived growth factor receptor a (PDGFRa) promoter is
detected in nuclei of all dorsal skin fibroblasts
(Figure 1aed). In neonatal (P2) skin, stem cell antigen 1
(Sca1) is absent from the upper (papillary) dermis but is
expressed by reticular fibroblasts, preadipocytes, and skin
adipocytes in the lower dermis (Donati et al., 2014; Driskell
et al., 2013; Festa et al., 2011). Immunolabeling confirmed
that most reticular fibroblasts express Sca1 at P2 (Figure 1c
and d). We have previously shown that fibroblasts that
express the protein Delta homolog 1 (Dlk1) at E16.5 give
rise to the Sca1þ fibroblasts and mature adipocytes present
in P2 and adult skin, although Dlk1 is no longer expressed
in adult skin (Driskell et al., 2013; Lichtenberger et al.,
2016). To compare fibroblasts from the upper and lower
dermis, we sorted EGFPþ cells from P2 dorsal dermis and
fractionated the cells further on the basis of Sca1 surface
marker expression (Figure 1e). We also sorted EGFP-/Sca1-
cells as a control., neq) Sections of P2 back skin from PdgfraEGFP mice showing expression of
Fabp4, and (p, q) Perilipin. (b, d, o, q) are enlargements of selected regions of
ating of different dermal subpopulations on the basis of PdgfraEGFP and Sca1
cell populations: PdgfraEGFP-/Sca1-, PdgfraEGFPþ/Sca1- and PdgfraEGFPþ/
d error of the mean of replicates from four mice. *P  0.05, **P  0.005,
1- cells. ad, adipocyte; epi, epidermis; der, dermis; EGFP, enhanced green
ry; PDGFRa, platelet-derived growth factor receptor a; ret, reticular.
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1132Quantitative real-time PCR (QPCR) analysis of mRNA
isolated from the different dermal subpopulations showed
that mRNAs corresponding to Pdgfra and the fibroblast
marker genes Col1a2 and Vimentin were highly enriched in
both Pdgfraþ subpopulations relative to Pdgfra- cells
(Figure 1feh), whereas mRNA corresponding to Ly6a (Sca1)
was highly enriched in the Pdgfraþ/Sca1þ fraction
(Figure 1i), confirming the relative purity of the sorted cell
populations. The adipocyte/preadipocyte marker genes
Fabp4, Perilipin, Pparg, and Dlk1 were also enriched in
Pdgfraþ/Sca1þ cells, consistent with previous reports
(Driskell et al., 2013; Festa et al., 2011) (Figure 1jem). The
QPCR results were confirmed by immunofluorescence
labeling of P2 dorsal skin with antibodies to Fabp4 and
Perilipin (Figure 1neq).
Differential expression of Wnt pathway genes in upper and
lower dermal fibroblasts
To explore the differences between Pdgfraþ/Sca1þ and
Pdgfraþ/Sca1- fibroblasts, we carried out gene expression
profiling using RNA from flow-sorted cells. We found that
1,457 entities were regulated by more than 2-fold (t test, P <
0.05) (Figure 2a; see Supplementary Table S1 online),
showing that global differences in gene expression distin-
guish the two fibroblast subpopulations. In addition to
differential expression of adipogenic genes, there was dif-
ferential expression of genes encoding zinc finger proteins
(Gupta et al., 2012) and regulators of the Wnt, BMP, Notch,
and PDGF signaling pathways (Figure 2b and c).
Because Wnt/b-catenin signaling is known to regulate
dermal development, the differential expression of genes
associated with this pathway was of particular interest
(Figure 2c). Several Wnt/b-catenin pathway genes were
differentially regulated in Pdgfraþ/Sca1þ and Pdgfraþ/Sca1-
fibroblasts, which we confirmed by QPCR in independent
biological samples (Figure 2dej). Pdgfraþ/Sca1þ fibroblasts
expressed significantly lower levels of Wnt5a ligand, the
Wnt receptor Frzb, and the Wnt effector Lef1, as well as
several other Wnt pathway genes including Axin2 and Dkk1
(Figure 2deh; see also Driskell et al., 2013). However,
Sca1þ cells expressed significantly higher levels of the Wnt
receptor Fzd4 and the Wnt effector Tcf7l2 (Figure 2i and j).
Tcf7l2, commonly known as Tcf4, is expressed in human
adipose tissue, and gene variants are associated with sus-
ceptibility to Type 2 diabetes and inability to lose weight
after lifestyle interventions (Cauchi et al., 2006; Haupt et al.,
2010). There was no significant difference in b-catenin
mRNA levels in Pdgfraþ/Sca1- and Pdgfraþ/Sca1þ fibroblasts
at P2 (Figure 2k). However, immunostaining showed
differential protein expression of b-catenin in the upper
and lower dermis of neonatal skin, with high levels of
nuclear b-catenin in papillary fibroblasts and only few
nuclear b-cateninepositive cells within the adipose tissue
(Figure 2lep).
Consistent with the microarray and QPCR data, immu-
nostaining of neonatal skin with antibodies recognizing
Tcf3/4 and Lef1 showed that Tcf3/4 localized to the lower
reticular dermis (Pdgfraþ/Sca1þ), whereas Lef1 stained the
upper papillary dermis (Pdgfraþ/Sca1-) (Figure 2n, q, and r).
However, there were some scattered cells in the lowerJournal of Investigative Dermatology (2016), Volume 136dermis that coexpressed Tcf3/4 and Lef1 (Figure 2n, white
arrowheads).
We conclude that neonatal dermis is compartmentalized
such that Wnt/b-catenin signaling pathway components are
differentially expressed in Sca1þ and Sca1- fibroblasts.
Constitutive b-catenin stabilization in postnatal skin
fibroblasts reduces the adipocyte layer and disturbs
the hair growth cycle
Given the inhibitory effect of Wnt/b-catenin signaling on
adipogenic differentiation (Gesta et al., 2007; Kennell and
MacDougald, 2005; Longo et al., 2004), we speculated that
activating the pathway in postnatal skin fibroblasts would
change the composition of the dermis by altering neonatal
fibroblast lineages or differentiation. To determine the effect
of active Wnt/b-catenin signaling in all neonatal fibroblasts,
we produced crosses between PdgfraCreERT2 (Rivers et al.,
2008) and Ctnnb1 Exon3Flox/þ (Harada et al., 1999) mouse
strains. Recombination of Ctnnb1 Exon3Flox/þ (referred as
cDex3) produces a variant of b-catenin that is resistant to
phosphorylation by glycogen synthase kinase 3b and degra-
dation by the adenomatous polyposis complex. Littermates
were treated topically with 4-hydroxy-tamoxifen (4-OHT) on
the day of birth and analyzed at different time points there-
after (Figure 3a).
By generating triple transgenics through crossing Pdgfra-
CreERT2, Rosa-CAG-LSL-tdTomato (tdTomato-LSL), and
Ctnnb1 Exon3Flox/þ mice, we could show equal recombina-
tion efficiency whether or not b-catenin was stabilized. Fifty
percent to 60% of all Pdgfraþ fibroblasts were tdTomatoþ at
P4 in control and mutant (cDex3) littermates (Figure 3b; see
Supplementary Figure S1a online). tdTomatoþ cells isolated
from back skin at P4 did not express a6 integrin (a marker of
epidermal keratinocytes), CD31 (endothelial cell marker),
CD45 or other markers of hematopoietic lineages (see
Supplementary Figure S1a, and data not shown).
The recombination efficiency was similar in different
fibroblast subpopulations (Figure 3b). Lrig1þ/Sca1- cells are
resident in the papillary dermis; Dlk1þ/Sca1- cells are a
subpopulation of P2 reticular fibroblasts; Sca1þ cells, which
can be Dlk1þ or Dlk1-, are found in the lower dermis and
subdermal fat layer (Driskell et al., 2013). Analysis of skin
sections confirmed that tdTomatoþ cells were present in all
dermal layers (Figure 3c and d).
A high abundance of nuclear b-catenin was detected in
tdTomatoþ fibroblasts of cDex3 skin at P4 (see Supplementary
Figure S1cef) and was even more pronounced at P56
(Figure 3eeh). Furthermore, QPCR showed increased (albeit
not significant) expression levels of known Wnt/b-catenin
target genes such as Nov, Sp5, and Gpr165 (Hamburg-
Shields et al., 2015) in flow-sorted tdTomatoþ fibroblasts
isolated from mutant skin compared with control skin (see
Supplementary Figure S1g) at P4. Interestingly, at P56
expression levels of Nov were similar in tdTomatoþ/Sca1-
fibroblasts in wild-type and mutant dermis but significantly
up-regulated in tdTomatoþ/Sca1þ fibroblasts, thereby reach-
ing similar levels between papillary and reticular fibroblasts
(see Supplementary Figure S1h).
No differences in skin morphology were observed between
mutant and control mice at P4 (Figure 3i and j). However, at
Figure 2. Distinct transcriptional signature of PdgfraEGFPD/Sca1D dermal cells. (a) Heat map showing hierarchical clustering (based on entities and samples)
of all differentially regulated genes (P< 0.05, change>2-fold) between PdgfraEGFPþ/Sca1þ and PdgfraEGFPþ/Sca1- fibroblasts. (b) Selected genes up-regulated
or down-regulated in Sca1þ cells. Values in parentheses represent fold change of each gene. (c) Heat map showing hierarchical clustering (based on entities) of
all regulated genes in the Gene Ontology term “Wnt receptor signaling pathway”. (dek) Quantitative real-time PCR analysis of mRNA levels in sorted cell
populations, normalized to Gapdh gene expression. Error bars represent standard error of the mean of replicates from four mice. *P  0.05, **P  0.005, ***P 
0.0005 compared with GFP- cells; #P  0.05 compared with GFPþ/Sca1- cells. (l, m) Immunofluorescent staining of neonatal skin with an antibody detecting b-
catenin. Red arrowheads show b-cateninþ fibroblasts in the reticular dermis. 40, 6-diamidino-2-phenylindole labels nuclei. Scale bar ¼ 200 mm. (n) Section of
P1 back skin immunostained for Tcf3/4 (red) and Lef1 (green). White arrowheads indicate double-labeled cells. Dashed lines demarcate epidermal-dermal
boundary. Scale bar ¼ 100 mm. (oer) Higher-magnification images of the boxed areas in (m, n), showing upper (o, q) and lower (p, r) dermis. BMP, bone
morphogenic protein; DAPI, 40, 6-diamidino-2-phenylindole; GO, Gene Ontology; PDGF, platelet-derived growth factor.
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Figure 3. b-Catenin stabilization in dermal fibroblasts via PdgfraCreERT2. (a) Schematic illustration of experimental strategy. (b) Recombination efficiency
of PDGFRaCreERT2. Bar graph showing percentage of tdTomatoþ cells within different fibroblast subsets after gating for ITGA6-/LIN-/CD31- cells 2 days after
4-OHTemediated recombination. Data are reported as mean  standard error of the mean of triplicate samples in a representative experiment (n ¼ 2e3
independent experiments). (c, d) tdTomato expression in 4-OHTetreated dorsal skin from (c) PDGFRaCreERT2  tdTomato-LSL  Ctnnb1 Exon3þ/þ (control)
and (d) PDGFRaCreERT2  tdTomato-LSL  Ctnnb1 Exon3Flox/þ (cDex3) mice at P4. (eeh) Strong b-catenin staining is detected in tdTomatoþ fibroblasts of mice
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b-Catenin Regulates Fibroblast LineagesP18 we observed fibroblast-rich regions within the adipocyte
layer of cDex3 mice (Figure 3k and l). At P35 these fibrotic
regions were prominent (Figure 3m and n), and at P56 the
adipocyte layer had been largely replaced by fibrotic dermis
(Figure 3o and p).
To assess whether Wnt/b-catenin signaling in fibroblasts
affects the hair cycle, we classified different stages of HFs
according to their morphology (Muller-Rover et al., 2001;
Paus et al., 1999) and also examined their length. For each
time point we examined at least 8 HFs per skin sample and
skin biopsies from 2e8 different mice of the same genotype.
We examined skin at P4 and P11 (n ¼ 3e4), during the
growth phase of HF morphogenesis; at P18 (n ¼ 3e5), P24
(n ¼ 2e4), and P28 (n ¼ 2), during the first postnatal telogen;
at P35 (n ¼ 6), during anagen; and at P42 (n ¼ 4e8) and P56
(n ¼ 3e6), when the follicles are entering catagen and the
second telogen, respectively. Regardless of genotype and age,
all HFs were synchronized, with the exception of P35 cDex3
mice, when two of eight mice were still in telogen and the
others were in anagen.
HF morphogenesis occurred normally in cDex3 mice (day
4 and 10; Figure 3q and r), as did the first telogen (day 18)
and first anagen (day 35; Figure 3q and r). However, from day
42 the hair cycle was disturbed in both male (Figure 3q) and
female (Figure 3r) cDex3 mice, and cDex3 follicles remained
in anagen, as assessed both by morphology and length, when
wild-type follicles were entering telogen (Figure 3oer). Based
on the observation that in two of eight mutant mice the HFs
were still in telogen at P35, which were not scored in
(Figure 3m and n), we speculate that there may be an
extended growth phase before the second catagen. This is
supported by the observation that there was an increased
number of proliferating phosphohistone H3þ cells in the
outer root sheath of HFs in mutant mice (Figure 3s). Never-
theless, the HFs in mutant skin eventually entered catagen,
and all HFs were in telogen at the age of 3 months (n ¼ 4; see
Supplementary Figure S1i and j). Thus, our findings indicate
that fibroblast-specific b-catenin stabilization perturbs the
hair cycle and extends anagen.
Constitutive b-catenin activation results in dermal fibrosis
To characterize the effect of activated Wnt/b-catenin
signaling in fibroblasts, we focused on P35 skin (Figure 4).
The fibrotic areas within the adipose layer of cDex3 dermis
labeled pink with the histochemical Herovici’s stain,
indicative of the mature fibrillar collagen (Collins et al.,
2011) (Figure 4a and b). QPCR showed reduced expres-
sion of differentiation markers such as Fabp4, Perilipin, and
Cebpa (Figure 4c) in mutant tdTomatoþ/Sca1þ fibroblasts
compared with controls. Immunostaining confirmed
reduced protein expression of Perilipin and Fabp4 but
showed higher levels of the preadipocyte marker Cd24with activated Wnt/b-catenin signaling. Note that the PDGFRaCreERT2 transgene
heads in (h) depict b-cateninþ cells in the dermal papilla. (iep) Paraffin sections
and eosin at (i, j) P4, (k, l) first telogen (P18), (m, n) anagen (P35), and (o, p) se
inserts. Scale bars ¼ 200 mm. (q, r) Hair follicle length measured in (q) male and
P56 (n ¼ 2e8). Data points are reported as mean  standard error of the mean.
sheath of hair follicles in immunostained skin sections (n ¼ 3 biological sample
tamoxifen; ctr, control; Dapi, 40, 6-diamidino-2-phenylindole; K14, keratin 14.(Figure 4dei). The reduction in the number of differentiated
adipocytes was confirmed by LipidTox (Invitrogen/Thermo
Fisher Scientific, Waltham, MA) staining (Figure 4j and k)
and was statistically significant (Figure 4l). Fibroblast pro-
liferative activity, measured by 5-Ethynyl-2’-deoxyuridine
(EdU) labeling, was increased in both the adipocyte layer
and in the rest of the dermis, including papillary fibroblasts
of the dermal sheath and reticular fibroblasts, the effect
being most pronounced in the adipocyte layer
(Figure 4meo). However, we did not detect significant
numbers of EdUþ DP cells, consistent with our previous
finding that the number of proliferating cells in adult DP is
very low, even when b-catenin is stabilized and the DP
increases in size (Kaushal et al., 2015).
Selective Wnt/b-catenin stabilization in Dlk1D fibroblasts
results in fibrosis within the adipose layer
Given the differential expression of adipogenic genes in
Sca1þ and Sca1- fibroblasts at P2 (Figure 2) and the fibrosis
within the adipose layer on fibroblast-specific stabilization of
b-catenin (Figure 3), we hypothesized that the fibrotic effect of
activating Wnt/b-catenin signaling in all Pdgfraþ fibroblasts
would be reproduced by selectively targeting the lower
dermal lineage during skin development. Because fibroblasts
that express Dlk1 at E16.5 give rise to the Sca1þ fibroblasts
andmature adipocytes present at P2 and in adult skin (Driskell
et al., 2013), we crossed Ctnnb1 Exon3Flox/þ, Dlk1CreERT2,
and tdTomato-LSL mice and treated them with tamoxifen at
E16.5 to target the lower dermal lineage (Figure 5a).
When fibroblasts were isolated at E18.5, 2 days after
tamoxifen injection in utero, 3% of total Pdgfraþ fibroblasts
were labeled (Figure 5b; Figure S1b). Ten percent to 15% of
Dlk1þ/Sca1- and Dlk1þ/Sca1þ cells were labeled, compared
with 2% of Dlk1-/Sca1þ cells (Figure 5b; see Supplementary
Figure S1b) and 1% of Lrig1þ papillary fibroblasts, confirming
the selectivity of targeting. tdTomatoþ fibroblasts comprised
30% Dlk1þ/Sca1-, 55% Dlk1þ/Sca1þ cells, and 10% Dlk1-/
Sca1þ cells (Figure 5c). It is most likely that tdTomatoþ cells
within the Dlk1-/Sca1þ fibroblast population correspond to
cells that were Dlk1þ at E16.5 but subsequently down-
regulated Dlk1 expression (Driskell et al., 2013). When
examined at P56, tdTomatoþ cells were confined to the lower
dermis in both control and Dlk1LTDex3 skin (Figure 5d and e).
In control skin most tdTomatoþ cells had the morphology of
mature adipocytes, whereas in Dlk1LTDex3 skin the tdTomatoþ
cells had a fibroblastic morphology (Figure 5d and e; mature
adipocytes are labeled with asterisks in Figure 5d).
In contrast to the effect of activatingWnt/b-catenin signaling
in all fibroblasts, selective activation in Dlk1þ cells did not
disturb the hair cycle, and at P56both control andDlk1LTDex3
skinwas in telogen (Figure 5f andg).Nevertheless, therewasan
accumulation of fibroblasts within the adipose layer inis also active in cells of the dermal papilla (white arrowheads in g). Red arrow
of back skin of control and mutant (cDex3) littermates stained for hematoxylin
cond telogen (P56). Boxed areas in (k, l) are shown as higher-magnification
(r) female cDex3 and control mice at P4, P11, P18, P24, P28, P35, P42, and
(s) Quantification of proliferating, phosphohistone H3þ cells in the outer root
s; 5 hair follicles per biological sample were scored). 4-OHT, 4-hydroxy-
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Figure 4. Induction of dermal fibrosis and proliferation by b-catenin stabilization. (a, b) Herovici’s staining differentiates between immature collagen fibers
(blue) versus mature collagen (pink). Note fibrotic region with mature extracellular matrix in (b) (boxed). (c) Relative expression of adipocyte differentiation
genes in flow-sorted tdtomatoþ fibroblasts. Data represent mean  standard error of the mean (n ¼ 3). *P  0.05. (dei) Immunostained paraffin sections of 35-
day-old mutant and control skin. (j, k)Whole-mount thick sections stained with LipidTox (green) with DAPI counterstain (blue). (l, m) Quantification in paraffin
sections of P35 skin of (l) adipocytes and (m) EdUþ fibroblasts in the adipocyte layer and interfollicular dermis (including papillary fibroblasts, dermal sheath,
and reticular fibroblasts). The boundary between papillary/reticular and adipocyte layers was defined by the interface between the bottom of the reticular layer
and the upper layer of differentiated adipocytes. Data points represent mean  standard error of the mean; n  5 for each group. *P  0.05; **P  0.005; ***P 
0.0005. (n, o) Skin labeled with EdU (green) for 4 hours before harvesting, costained for Pdgfra (red), keratin 14 (white), and DAPI (blue). White arrowheads
indicate EdUþ fibroblasts within the adipose layer. Inserts are higher-magnification images of the boxed areas. Scale bars ¼ 200 mm. ctr, control; DAPI, 40, 6-
diamidino-2-phenylindole; K14, keratin 14.
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Figure 5. b-Catenin stabilization in the lower dermis via Dlk1CreERT2. (a) Schematic illustration of experimental strategy. (b, c) Quantification of tdTomatoþ
cells in E18.5 dermal cell suspensions (ITGA6-/LIN-/CD31-) 2 days after 4-OHT injection. (b) Percentage of tdTomatoþ cells in each fibroblast subpopulation.
(c) Contribution of each fibroblast subpopulation to tdTomatoþ fibroblasts. Data are presented as mean  standard error of the mean of quadruplicate samples in
a representative experiment (n ¼ 3 independent experiments). (d, e) tdTomato-expressing cells in P56 back skin of Dlk1CreERT2  tdTomato-LSL  Ctnnb1
Exon3þ/þ (control) and Dlk1CreERT2  tdTomato-LSL  Ctnnb1 Exon3Flox/þ (Dlk1LTDex3) mice. Asterisks in (d) indicate terminally differentiated adipocytes. (f,
g) Hematoxylin and eosin and (h, i) Herovici’s staining of paraffin sections of P56 control and Dlk1LTDex3 mouse back skin. Arrows in (g) and (i) indicate
fibrotic regions. (jem) P56 control and Dlk1LTDex3 back skin labeled for b-catenin or caveolin-1 and keratin 14, counterstained with DAPI. Vertical lines
indicate thickness of adipocyte layer. Dashed line in (k) demarcates fibrotic tissue (FT). (n, o) Quantification of fibrotic area shown as percentage of the
adipocyte layer (n) and number of adipocytes (o). (p) Quantification of EdU-labeled fibroblasts in the interfollicular dermis (including papillary fibroblasts,
dermal sheath, and reticular fibroblasts) and adipose layer (defined as in Figure 4m) after a 2-hour EdU pulse. Data are presented as mean  standard error of the
mean of triplicate samples in a representative experiment (n ¼ 3e5). *P  0.05; **P  0.005. (q, r) EdU staining of sections shown in (d) and (e). Scale bars ¼
200 mm. 4-OHT, 4-hydroxy-tamoxifen; AL, adipocyte layer; ctr, control; DAPI, 40, 6-diamidino-2-phenylindole; K14, keratin 14.
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1138Dlk1LTDex3 skin (Figure 5f and g). These regions stained
positively for fibrillar ECMusingHerovici’s dye (Figure 5h and i)
and expressed high levels of b-catenin (Figure 5j and k). The
reduction in adipocyte numbers was confirmed by labeling for
caveolin-1, a marker for preadipocytes and adipocytes
(Figure5l andm) andwas statistically significant, in accordance
with the appearance of fibrotic lesions (Figure 4n and o).
Stabilization of b-catenin via Dlk1CreERT2 also resulted in an
increase in fibroblast proliferation both in the adipocyte layer
and throughout the dermis (Fig. 5per).
Postnatal Wnt/b-catenin stabilization inhibits adipogenesis
of Sca1D fibroblasts in culture
To establish whether b-catenin stabilization within pre-
adipocytes resulted in an inhibition of differentiation,
we analyzed the behavior of single cells captured in
ECM-functionalized hydrogels, as described previously
(Driskell et al., 2012; Driskell et al., 2013). PdgfraCreERT2,
tdTomato-LSL, and Ctnnb1 Exon3Flox/þ mice were crossed
and treated with 4-OHTon the day of birth (Figure 6a). Sca1þ
tdTomatoþ fibroblasts were isolated by flow cytometry
2 days later (Figure 6b and c). Activation of Wnt/b-catenin
signaling did not affect the proportion of Sca1þ cells that
expressed the preadipocyte marker Cd24 (Festa et al., 2011)
(Figure 6d).
Sca1þ cells were encapsulated at clonal density in
3-dimensional hydrogels and cultured in control or adipo-
genic medium. After 10 days in culture, individual clones
were scored for cell number and the total intensity of
LipidTox staining (Figure 6e). Whereas b-catenin stabilization
in vivo stimulated proliferation within the adipose layer
(Figure 4m), there was no effect on clone size when Sca1þ
cells were cultured in adipogenic medium, and in standard
medium the only effect was to increase the percentage of two
cell clones at the expense of clones with higher cell numbers
(Figure 6f and g). Wnt/b-catenin signaling activation did,
however, decrease adipocyte differentiation, as evaluated by
decreased LipidTox staining, both in standard medium
(Figure 6h) and in medium supplemented with adipogenic
factors, regardless of clone size (Figure 6i). These findings
suggest that the effect of b-catenin stabilization in neonatal
fibroblasts is to prevent Sca1þ fibroblasts from undergoing
adipocyte differentiation in a cell-autonomous manner, rather
than changing the proportion of Cd24þ/Sca1þ preadipocytes.
DISCUSSION
Here we have examined the effect of dermal Wnt/b-catenin
signaling in the context of fibroblast heterogeneity. We show
that expression of Wnt pathway genes such as Wnt5a, Lef1,
Tcf4, or Dkk1 differs between upper (Sca1-) and lower
(Sca1þ) dermis. Interestingly, immunostaining showed that
b-catenin and Lef1 are more abundant in Sca1- cells.
b-Catenin stabilization in all fibroblast populations in
neonatal skin resulted in a decrease in mature adipocytes and
the appearance of fibrotic regions in the adipose layer,
accompanied by stimulation of fibroblast proliferation
throughout the dermis. The replacement of adipocytes by
ectopic reticular fibroblasts also occurred when the lower
dermal lineage was selectively targeted at E16.5, before
adipocyte differentiation.Journal of Investigative Dermatology (2016), Volume 136Our in vitro studies showed that b-catenin stabilization
did not drive fibroblast proliferation cell-autonomously. The
effect of b-catenin stabilization was to inhibit terminal dif-
ferentiation of Sca1þ cells rather than to promote expansion
of preadipocytes or selective proliferation of reticular fibro-
blasts. This is similar to the effect of b-catenin stabilization on
cultured human keratinocytes, which is to expand the stem
cell compartment without stimulating proliferation (Zhu and
Watt, 1999). However, although we did not detect an
expansion of preadipocytes within 4 days of b-catenin sta-
bilization in vivo, Cd24 expression was increased in P35
skin. This could either be caused by an expansion of pre-
adipocytes at a later stage, which is supported by increased
fibroblast proliferation in vivo, or by the differentiation
defect.
Our conclusion that targeting the lower dermal lineage
accounts for the appearance of fibrotic regions is consistent
with other studies highlighting the contributions of different
dermal cell subpopulations to fibrosis. For example, fibro-
blasts that express engrailed 1 during development are
responsible for the bulk of ECM deposition in dorsal dermis
and mediate dermal fibrosis in response to irradiation
(Rinkevich et al., 2015). Other dermal subpopulations that
contribute to fibrosis include Sox2þ cells (Liu et al., 2014)
and adiponectin-positive adipocyte precursors (Marangoni
et al., 2015). In addition, Adam12þ perivascular mesen-
chymal cells expressing Pdgfra and Sca1 are profibrotic in
response to injury (Dulauroy et al., 2012).
The inhibition of adipocyte differentiation was not the only
effect of dermal b-catenin activation that we observed. There
was an increase in proliferation throughout the dermis,
consistent with an earlier report (Cheon et al., 2002), and a
disruption of the HF cycle. The effects on the hair cycle
cannot be attributed solely to a decrease in mature adipo-
cytes (Donati et al., 2014; Festa et al., 2011), because they
were observed when we targeted all fibroblast sub-
populations via PdgfraCreERT2 and not when we selectively
targeted the lower dermal lineage. This raises an interesting
question as to whether increased proliferation of the fibro-
blast subpopulations that are known to regulate hair growth,
in particular the DP, dermal sheath, and other papillary fi-
broblasts (Driskell et al., 2013; Enshell-Seijffers et al., 2010;
Kaushal et al., 2015), is responsible. We have previously
shown that b-catenin stabilization in Prominin-1eexpressing
DP cells results in an increase in DP size, but because the
number of EdUþ cells is very low, the increase could be
attributable to a number of factors, such as increased
migration from the dermal sheath (Kaushal et al., 2015).
Because the PdgfraCreERT2 transgene is active in DP cells
(Figure 3g and h), it is possible that the perturbed hair cycle
reflects, at least in part, Wnt/b-catenin activation in DP cells.
The effect of b-catenin stabilization on proliferation in the
upper and lower dermis could either be direct or indirect. An
indirect effect could be via dermal ECM, because Tcf-
mediated transcription of several ECM protein-coding genes
has recently been shown in a fibrosis model of sustained
b-catenin activity in Hoxb2-derived ventral fibroblasts
(Hamburg-Shields et al., 2015).
Our findings are in good agreement with previous reports
that b-catenin plays a role in skin fibrosis (Beyer et al., 2012)
Figure 6. Effect of b-catenin stabilization on adipocyte differentiation in cultured Sca1D fibroblasts. (a) Schematic illustration of experimental strategy. (bed)
Sca1þ/tdTomatoþ targeted fibroblasts from dermal cell suspensions of PDGFRaCreERT2  tdTomato-LSL  Ctnnb1 Exon3þ/þ (control) and PDGFRaCreERT2 
tdTomato-LSL  Ctnnb1 Exon3Flox/þ (cDex3) littermates were isolated by flow cytometry. (b, c) Gating out a6 integrin-positive cells (ITGA6; keratinocytes) (b)
and positive selection for Sca1þ/tdTomatoþ cells (c). (d) Recombination efficiency (percentage tdTomatoþ cells) in Cd24þ/Sca1- and Cd24-/Sca1þ cells. Data are
presented as mean  standard error of the mean of triplicate samples in a representative experiment (n ¼ 3 independent experiments). (e) Examples of individual
colonies formed by Sca1þ fibroblasts stained for LipidTox (green), tdTomato (red), and DAPI (blue). Scale bars ¼ 10 mm. (f, g) Percentage of colonies containing
1, 2, 3e5, or more than 5 cells in standard (f) and adipogenic (g) medium. (h, i) Total LipidTox fluorescence (lipid intensity) per clone in control and mutant
(cDex3) cultures grown in standard (h) or adipogenic (i) medium. (fei) n ¼ 2e3 biological replicates and 2 technical replicates. *P  0.05, **P  0.01, ***P 
0.005. (f, g) two-way analysis of variance with a Bonferroni posttest. (h, i) 25% confidence intervals are shown. 4-OHT, 4-hydroxy-tamoxifen; ctr, control DAPI,
40, 6-diamidino-2-phenylindole; FSC, forward scatter; ns, difference not significant.
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ways, such as cEBP/PPARg, in culture (Gesta et al., 2007). In
addition, expression of the Wnt inhibitor Dkk1 interferes
with profibrotic signaling (Akhmetshina et al., 2012).
Together, these studies suggest that pharmacological modu-
lation of Wnt signaling could be beneficial in the treatment of
fibrotic skin diseases, including scleroderma (Ohgo et al.,
2013). Similar mechanisms could also be responsible
for the regulation of mesenchymal progenitors in other or-
gans, including Pdgfraþ/Sca1þ muscle fibroblasts with pro-
liferative and myofibroblast/adipogenic potential in response
to muscle regeneration and ectopic fat formation (Uezumi
et al., 2010).MATERIALS AND METHODS
In vivo experiments
The following mouse strains were maintained on a C57 Bl6/CBA
background: Dlk1CreERT2 Institut Clinique de la Souris (ICS, Illkirch-
Graffenstaden Cedex Alsace, France), PdgfraEGFP (PdgfraH2B-
eGFP) (Jackson Laboratories, Bar Harbor, ME), Ctnnb1lox(ex3)/þ
(Harada et al., 1999). PdgfraCreERT2 (Rivers et al., 2008) and Rosa-
CAG-LSL-tdTomato (Jackson Laboratories; 007905) strains were
maintained as homozygotes. Cre-mediated recombination was
induced by topical application of 2 mg of 4-hydroxy-tamoxifen
(Sigma, St. Louis, MO; diluted in acetone þ 10% DMSO) on the
back skin of neonatal pups at P0eP1. For lineage tracing experi-
ments, plugged females received a single intraperitoneal injection ofwww.jidonline.org 1139
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dissolved in corn oil (10e20 mg/ml) by intermittent sonication at
37C for 20e30 minutes. Pups were harvested and fostered after
surgical removal between E18.5 and E21. For in vivo proliferation
assays, mice received a dose of 500 mg 5-ethynyl-20-deoxyuridine
(EdU; 2.5mg/ml in phosphate buffered saline) by intraperitoneal
injection 2e4 hours before they were killed. Cohorts included male
and/or female littermates, and results are representative of at
least three biological samples. All experimental procedures were
carried out under the terms of a UK Home Office project license
after ethical review at Cambridge University or King’s College
London.
Histology
Skin samples were harvested and processed to generate paraffin
(5 mm) or thick cryopreserved whole-mount tissue (50e100 mm)
sections as previously described (Collins et al., 2011; Driskell et al.,
2013). Immunostaining was performed using the following antibody
combinations: rabbit anti-Rfp (1:300; Rockland, Limerick, PA)/rabbit
anti-Perilipin 1A (1:100; Abcam, Cambridge, UK)/rabbit anti-
Caveolin-1 (1:100; Abcam); rabbit anti-Fabp4 (1:100; Abcam);
donkey anti-rabbit Alexa Fluor 555, 594, or 488; goat anti-PDGFRa
and goat anti-Sca1 (1:100; R&D Systems, Minneapolis, MN); donkey
anti-goat Alexa Fluor 488 or 647; chicken or rabbit anti-Keratin 14
(1:100; Covance, Princeton, NJ); goat anti-chicken Alexa Fluor 647
or 555; mouse b-catenin (1:100; BD Transduction, Lexington, KY);
donkey anti-mouse Alexa Fluor 594 or 488; rabbit anti-TCF3/4
(1:100; Abcam) and anti-Lef1 (1:100; Cell Signalling, Danvers,
MA); Alexa Fluor 488 conjugated anti-CD24 (1:300; BD Pharmin-
gen, Franklin Lakes, NJ). LipidTox (1:500 in phosphate buffered sa-
line; Invitrogen/Thermo Fisher Scientific, Waltham, MA) was used to
stain neutral lipids in adipocytes. ProLong Gold antifade reagent
(Invitrogen) or glycerol was used for mounting slides or whole-
mount sections, counterstained with 40, 6-diamidino-2-
phenylindole (DAPI). The EdU click-it imaging kit (Invitrogen) was
used for detecting incorporated EdU nucleoside analogs in prolif-
erating cells. Herovici’s staining was performed as previously
described (Collins et al., 2011).
Image acquisition and quantification
Immunostained tissue sections were imaged using a Nikon A1R
confocal microscope. Adobe Photoshop CS6 (Adobe, San Jose, CA)
was used to adjust images and correct background. Bright field
images were collected using either a Hamamatsu NanoZoomer slide
scanner (Hamamatsu, Japan) or a Zeiss Axiophot microscope (Carl
Zeiss, Oberkochen, Germany) with a 10 objective and an Axio-
Cam HRc camera. Image measurements were performed on at least
six microscopic fields per biological sample.
Cell isolation and flow cytometry
Dermis was separated from back skin of embryos (E18.5eE19.5) or
postnatal pups (P2eP4) by incubation with thermolysin (0.25
mg/ml) (Sigma T7902) overnight at 4C, digested in Dulbecco’s
Modified Eagle’s Medium þ 10% fetal bovine serum containing 2.5
mg/mL collagenase I (Gibco 17100-017; Gibco/Thermo Fisher
Scientific, Waltham, MA), and further processed as previously
described (Collins et al., 2011). Cells were labeled in phosphate
buffered saline þ 10% fetal bovine serum TruStain fcX anti-mouse
blocking buffer with the following antibodies: anti-mouse Ly-6A/E
(Sca-1)-Alexa Fluor 488, 700, or BV605 (clone D7; 1:200);
CD140a/Pdgfra-APC (clone APA5; 1:20); CD45-Alexa Fluor 700Journal of Investigative Dermatology (2016), Volume 136(clone 30-F11; 1:100); CD24-Fitc (Clone M1/69; 1:100) (eBio-
science, San Diego, CA); Lrig1-Alexa Fluor 488 (polyclonal; 1:20)
(RnD Systems); anti-rat Dlk1-Fitc (clone 24-11; 1:20) (MBL Inter-
national, Woburn, MA); anti-mouse-CD31-Alexa Fluor 647 (BD
Pharmingen); APC Mouse Lineage Antibody Cocktail (BD Phar-
mingen); and anti-human CD49f-Alexa Fluor 647 (clone NKI-
GoH3; 1:20) (AbD Serotec, Kidlington, UK). A BD LSRFortess a
(Becton Dickinson, Franklin Lakes, NJ) was used for flow cytometry
and an Aria II (Becton Dickinson, Franklin Lakes, NJ) for sorting
fibroblasts. Dead cells were excluded from analysis using DAPI.
Fibroblasts were either sorted for CD140a expression or negatively
selected by excluding epidermal, endothelial, and immune cells
from the cell suspension (ITGA6-/LIN-/CD31-). Data analysis and
visualization were performed using FlowJo software version 7.6.5
(Tree Star, Ashland, OR).
Hydrogel culture and high-content imaging
Sorted fibroblasts were collected and encapsulated in Extracel
(Glycosan Biosystems) as previously described (Driskell et al.,
2012), at a density of 5  105/ml in mClear 96-well plates
(Corning). Cultures were maintained for 10 days at 37C/5% CO2 in
standard medium (Dulbecco’s modified Eagle’s medium þ 10% fetal
bovine serum þ 1% penicillin/streptomycin) or Adipogenic medium
(StemXVivo Osteogenic/Adipogenic Base Media with Adipogenic
Supplement; R&D Systems), and the medium was changed every
2e3 days.
Cultures were fixed with 4% paraformaldehyde for 10 minutes,
washed twice in phosphate buffered saline, permeabilized with
0.1% Triton X-100 for 5 minutes and stained with LipidTox, DAPI,
and rabbit anti-Rfp (1:300 dilution; Abcam). Multiple image stacks of
each colony were recorded using an Operetta High Content Imaging
system (Perkin Elmer, Waltham, MA). Spheres were identified by
staining for tdTomato, and the number of nuclei per sphere was
determined using quantification algorithms in the Columbus analysis
software (Perkin Elmer, Waltham, MA). The fluorescence intensity of
LipidTox staining was measured for each sphere.
Quantification and Statistics
GraphPad Prism 6 software (GraphPad Software Inc., La Jolla, CA)
was used for all analyses of numerical data and generation of graphs
and statistical tests, including one-way analysis of variance or Stu-
dent t test. Error bars represent standard error of the mean.
Microarray
Genome-wide expression profiling was carried out by the Pater-
son Institute Microarray Core Facility, as described previously
(Collins et al., 2011). The data are deposited in the National In-
stitutes of Health GEO repository under accession number
GSE76751. Complementary DNA was hybridized to Affymetrix
MG430.2A arrays (Affimetrix, Santa Clara, CA). Array images
produced by the Affymetrix PICR 3000 scanner were imported as
CEL files into Genespring GX11 (Agilent Technilogies, Santa
Clara, CA) for analysis. Robust Multi-array Average normalization
(baseline to median of all samples) was used. Analyses were
performed on genes selected for expression above the bottom
20th percentile in all three samples within at least one of two
experimental groups. To identify differentially expressed genes,
we compared the two groups using the Student t test (P-value cut-
off of 0.05). Entities regulated by greater than 2-fold were selected
for further analysis.
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